Both in Blank Checks
Drugs Made In America Acquisition vs Xterax Corporation II
Over the past year DMAA returned +0.8% and XTER returned −0.4%; their daily moves had a correlation of 0.02.
DMAA +0.8% XTER −0.4%Growth of $1, one year, split-adjusted
| Metric | DMAA | XTER |
|---|---|---|
| Price | $10.89 | $9.78 |
| Market cap | $264.4M | $267.2M |
| Today | 0.00% | +0.10% |
| 1 month | +0.4% | −0.1% |
| 6 months | +2.7% | — |
| Year to date | +5.0% | — |
| 1 year | — | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | -$329.7K | — |
| Dividend yield | — | — |
| Volatility (60d) | 1.8% | — |
| Short % of float | 0.4% | 0.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).